TNNI3 and myocardial infarction: Likewise, our research was the first to explore the effect of iguratimod on myocardial I/R injury, and the results demonstrated that iguratimod reduced the myocardial infarct size, cTnI level in serum, and pathological changes of cardiac tissue, indicating its cardioprotective role.